Create your own personalized MyJanssenCarePath account to:
- Check your insurance coverage
- Enroll in the Janssen CarePath Savings Program, if eligible
- Sign up for personal treatment reminders
Patient Authorization Form — Allows you to authorize the use of your personal information for Janssen CarePath support programs.
Janssen CarePath Savings Program Overview — Provides information on the Janssen CarePath Savings Program for DARZALEX FASPRO™ and eligibility requirements for enrolling in the program.
Janssen CarePath Savings Program Oncology Patient Assignment of Benefits — Allows you to authorize your provider to receive your Janssen CarePath Savings Program rebate on your medication on your behalf.
Patient Affordability Options for DARZALEX FASPRO™ — Gives information on options that can make your treatment more affordable.
Medicare Resource Guide — Provides information on sources for cost support that may be available to patients enrolled in Medicare.
Medicare Part D and Coverage Gap Guide — Helps you understand the 4 phases of coverage (Deductible, Initial Coverage, Coverage Gap, and Catastrophic Coverage), and when you will enter the Coverage Gap (formerly known as the Donut Hole).
Medicare Low-Income Subsidy (LIS) Brochure — Offers information about extra help with prescription drug costs that is available to low-income residents of the United States enrolled in Medicare Prescription Drug Plans.
Advocacy Connector — A Janssen-sponsored resource that connects patients and caregivers to national and state-specific advocacy groups that offer resources that may be relevant to your needs.
Johnson & Johnson Patient Assistance Foundation (JJPAF) — An independent, nonprofit organization committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies.
DARZALEX FASPRO™ is a prescription medicine used to treat adult patients with multiple myeloma:
It is not known if DARZALEX FASPRO™ is safe and effective in children.
Do not receive DARZALEX FASPRO™ if you have a history of a severe allergic reaction to daratumumab or any of the ingredients in DARZALEX FASPRO™.
Before you receive DARZALEX FASPRO™, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
DARZALEX FASPRO™ may cause serious reactions, including:
The most common side effects of DARZALEX FASPRO™ when used alone include cold-like symptoms (upper respiratory infection).
The most common side effects of DARZALEX FASPRO™ used in combination therapy include:
These are not all the possible side effects of DARZALEX FASPRO™. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
General information about the safe and effective use of DARZALEX FASPRO™
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. You can ask your healthcare provider or pharmacist for information about DARZALEX FASPRO™ that is written for health professionals.
Active ingredient: daratumumab and hyaluronidase-fihj
Inactive ingredients: L-histidine, L-histidine hydrochloride monohydrate, L-methionine, polysorbate 20, sorbitol, water for injection
Please click here to see the Product Information.